LymeHQ · Integrative Reference

Integrative & Natural Approaches:What Patients Use, What the Evidence Shows

Many in the Lyme community use natural and supportive approaches alongside conventional treatment. This guide describes them honestly — clearly labeling what's backed by human clinical studies, what's only been studied in the lab, and what comes from community experience without formal evidence.

This is educational information, not medical advice, and not a substitute for treatment. Nothing here treats or cures Lyme disease or any tick-borne illness. These approaches are described as supportive measures used alongside conventional medical care — never as replacements for it. For an active infection, antibiotics prescribed by your provider are the evidence-based treatment. Always discuss anything you're considering with your provider, especially because some natural products interact with medications.
Evidence KeyClinical — human studies existPreclinical — lab/in-vitro onlyCommunity — anecdotal, unstudied
Review statePending clinical review

Every approach listed, and the evidence tier assigned to each. A clinically-informed reviewer has not yet signed this off, and it stays marked until one does.

Two sets of guidance, and where they part

Three questions, and what each set of guidance says in answer to them.

Where two sets of tick-borne disease guidance differTwo sets of guidance answer the same questions differently, and neither is presented as the settled answer. On how long to treat, IDSA and CDC guidance describes a defined course and holds that longer courses have no proven benefit, while ILADS guidance allows longer or repeated courses, decided case by case. On whether infection can persist, IDSA and CDC guidance holds that persistence is not established and calls continuing illness post-treatment syndrome, while ILADS guidance considers persistence possible and says it may explain ongoing symptoms. On how much the test decides, IDSA and CDC guidance has serology guide the diagnosis, with two-tier testing as the standard, while ILADS guidance allows the clinical picture to outweigh the test, given known test limitations. Both positions are held by practising clinicians.IDSA / CDCguidanceILADSguidanceHow long to treatA defined courseLonger courses:no proven benefitLonger orrepeated coursesDecidedcase by caseWhether infection can persistNot establishedCalled post-treatmentsyndromeConsideredpossibleAnd may explainongoing symptomsHow much the test decidesSerology guidesdiagnosisTwo-tier testingis the standardClinical picturecan outweigh itGiven known testlimitations

Both columns are the same size, in the same type, in the same colour. That is deliberate: this figure records a disagreement; it does not settle one.

Knowing which of the three questions is actually in front of you — how long, whether it persists, or how much the test decides — is what makes the next conversation a shorter one.

Both positions are held by practising clinicians. This shows where they differ; it is not a recommendation. Your treatment is a conversation with your own clinician.

Orientation only. No figure on this drawing is a measured quantity: the columns paraphrase the shape of two published positions in plain language, and carry no dose, no duration and no guideline version.

Lyme patients use integrative approaches more than almost any other patient group — often because the conventional system left them searching for answers. That makes honest information essential. The goal of this guide is not to tell you what works — for most natural approaches to Lyme, rigorous human evidence simply doesn't exist yet. The goal is to tell you, plainly, how much we actually know about each one, so you can make informed choices alongside your provider rather than relying on marketing or hope.

Every entry below is labeled by evidence tier. Where something is supported only by lab studies, we say so. Where it's used widely in the community but hasn't been studied, we label it as anecdotal — because you deserve to know the difference.

Herbal Antimicrobials

Plant compounds with documented antimicrobial activity in laboratory settings. Best understood as adjunctive support — most have not been tested in human Lyme clinical trials.

  • Japanese Knotweed (Resveratrol)

    Buhner protocol · anti-spirochetal

    Contains resveratrol and stilbene compounds. Notable for crossing the blood-brain barrier, making it one of the few herbs discussed in the context of neurological Lyme. Also acts as an anti-inflammatory through NF-κB modulation.

    Preclinical: Laboratory studies suggest anti-Borrelia activity and anti-inflammatory effects. No human clinical trials confirm efficacy for Lyme.

    Used as adjunctive support alongside conventional treatment, not as a replacement.

    Can interact with blood thinners. Discuss with your provider if you take anticoagulants.

  • Cryptolepis

    anti-parasitic · Babesia-directed

    A West African plant whose alkaloid cryptolepine interacts with DNA in protozoal parasites. Used in the community primarily for Babesia support.

    Preclinical: Some in-vitro studies suggest activity against Babesia. Human clinical evidence for Lyme/Babesia is lacking.

    Discussed as adjunctive support; conventional antiparasitic treatment (e.g., atovaquone + azithromycin) remains the evidence-based approach for Babesia.

    Discuss with your provider, especially if pregnant or on other medications.

  • Cat's Claw (Uncaria tomentosa)

    immune modulation

    Contains pentacyclic oxindole alkaloids that modulate NF-κB signaling — the same inflammatory pathway disrupted during Borrelia infection. Often described as an immune regulator rather than a stimulant, which matters for patients with dysregulated immunity.

    Preclinical: Lab studies suggest immune-modulating and possible anti-Borrelia activity. Not confirmed in human Lyme trials.

    Used as immune support alongside treatment.

Detox & Herxheimer Support

Measures the community uses to manage die-off (Herxheimer) reactions during treatment. Some have established mechanisms; their specific benefit for Lyme herx is largely experience-based.

  • Binders (Activated Charcoal, Cholestyramine, GI Detox+)

    endotoxin binding

    Work by adsorbing bacterial endotoxins in the gut before reabsorption, interrupting enterohepatic recirculation of toxins. A well-established mechanism in toxicology, applied by the community to reduce herx intensity.

    Community + mechanism: The binding mechanism is established; specific benefit for Lyme herx reactions is primarily reported through community experience rather than Lyme-specific trials.

    Cholestyramine is prescription; discuss any binder use with your provider.

    Critical timing: binders bind medications too — take at least 2 hours apart from all antibiotics and supplements, or they reduce drug absorption.

  • Glutathione & NAC

    antioxidant · detox support

    Glutathione is the body's master antioxidant, depleted during chronic infection and die-off. NAC is a precursor that also has shown anti-biofilm activity in lab settings. Used to reduce oxidative stress during herx.

    Preclinical + community: Antioxidant roles are well established generally; NAC's anti-biofilm activity is shown in vitro. Lyme-specific clinical benefit is not established.

    Supportive use alongside treatment.

Immune & Nutritional Support

Foundational nutritional support. These have the clearest general scientific basis — though their role is supporting overall health and immune function, not treating the infection itself.

  • Vitamin D3 + K2

    immune regulation

    Vitamin D receptors sit on virtually every immune cell, and deficiency is common in chronic illness. D3 modulates immune function; K2 directs calcium appropriately.

    Clinical (general): Vitamin D's role in immune function is well established in the broader literature, and deficiency correction is standard care. This supports immune health generally — it does not treat Lyme.

    Test levels with your provider; correct deficiency as part of overall health.

  • Probiotics

    gut microbiome · 70% of immune cells

    Antibiotics significantly disrupt the gut microbiome, where most immune cells reside. Restoring it supports immune function and reduces GI side effects of treatment.

    Clinical (general): Probiotics for antibiotic-associated gut disruption are well supported in general medicine.

    Especially relevant during and after antibiotic courses.

    Take 2+ hours after antibiotics, or the antibiotic kills the probiotic.

  • Magnesium, Omega-3s, CoQ10

    cofactors · anti-inflammatory · mitochondrial

    Commonly depleted in chronic illness. Magnesium supports nerve and muscle function and sleep; omega-3s modulate inflammation; CoQ10 supports mitochondrial energy production, relevant to Lyme fatigue.

    Clinical (general): Each has an established general evidence base for its respective role. Benefit in Lyme specifically is supportive/symptomatic, not curative.

    Supportive of overall recovery alongside treatment.

    Magnesium blocks doxycycline absorption — separate by 2+ hours.

Lifestyle & Supportive Practices

Not products — practices the community uses, several with strong general health evidence for supporting immune function and recovery.

  • Sleep, Stress Reduction, Gentle Movement

    immune function foundations

    Sleep deprivation reduces immune cell activity; chronic stress elevates cortisol, which suppresses immune response. Gentle movement supports circulation and lymphatic function without overtaxing a recovering body.

    Clinical (general): The links between sleep, stress, and immune function are well established. During Lyme treatment these are immune-function requirements, not lifestyle extras.

    Foundational support for any treatment approach.

  • Infrared Sauna, Epsom Salt Baths

    community comfort practices

    Widely used in the community for symptom comfort and a sense of supporting detoxification.

    Community: Used widely for comfort and perceived detox support. Lyme-specific evidence is anecdotal; benefits reported are largely symptomatic comfort.

    Heat can worsen symptoms or cause lightheadedness for some patients — start gentle, stay hydrated, and stop if you feel worse.

Community Reports

This guide grows with the community. Approaches patients report using are reviewed, then surfaced here in aggregate under the Community evidence tier — never as recommendations, always as signal.

Not built yet — Community-reported approaches

As community members share what's helped them, reviewed and approved reports will appear here in aggregate — for example, “147 community members report using [approach] alongside conventional treatment for [symptom].” Counts, not testimonials. Every entry will carry the Community evidence label and a reminder to discuss with your provider.

Community tier: Aggregated, moderated, and k-anonymized (shown only when 5+ people report the same approach). This is what people use — not medical advice, and not a recommendation.

Share what's helped you

Used something that helped, alongside your treatment, that isn't listed here? Tell us — your experience helps the community and contributes to research on what patients actually use. Submissions are reviewed before anything appears publicly, and are never published as individual medical claims.

Submitted to help research what the community uses — not medical advice. Never stop conventional treatment based on community reports.

⚙ Build-phase feature — submission → moderation queue → aggregated display.

The One Rule That Matters Most

Never use natural approaches in place of antibiotics for an active infection. Early Lyme is highly treatable with conventional treatment, and delaying it to try natural approaches alone can allow the infection to disseminate and become far harder to treat. Everything in this guide is supportive — meant to work with your medical care, never instead of it.

How Beacon Can Help

Beacon can help you organize questions about any approach here to bring to your provider, and explain what each evidence tier actually means for your decision. Beacon never tells you to start or stop a treatment — that's always a conversation with your provider, and how anything here combines with your current medications is exactly the kind of question to bring to it.
Find a Lyme-Literate ProviderTelehealth Network